Aethlon Medical, Inc.
AEMDNASDAQHealthcareMedical - Devices
Previous close
$2.73
+$0.03 · +1.11%
AEMD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
46
Fair Value
Momentum
20
Strong Down
Sentiment
66
Bullish
Risk resilience
25
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
Market position
Day range
Current $2.73
52-week range
Current $2.73
- Open
- $2.745
- Previous close
- $2.70
- Volume
- 37.47K
- Market cap
- 1.44M USD
- 50-day average
- $4.2438
- -35.67% below average
- 200-day average
- $10.955
- -75.08% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.68M USD
- P/E (TTM)
- -0.23×
- P/B (TTM)
- 0.2×
- P/S (TTM)
- 0×
- EV / EBITDA
- -0.39×
- Earnings yield
- -97.04%
- Free cash flow yield
- -95016466.85%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- -146.36%
- Return on assets
- -112.92%
- Return on invested capital
- -139.64%
Financial health
- Debt / equity
- 0.05×
- Current ratio
- 3.85×
- Altman Z-score
- -41.65
- Piotroski F-score
- 1 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 574.25K USD | 294.17K USD |
| Gross profit | — | — | — | 574.25K USD | 294.17K USD |
| Research and development | 1.91M USD | 2.21M USD | 2.52M USD | 2.75M USD | 2.34M USD |
| Selling, general, and administrative | 7.29M USD | 9.34M USD | 12.64M USD | 12.47M USD | 10.72M USD |
| Operating expenses | 7.29M USD | 9.34M USD | 12.64M USD | 12.47M USD | 10.72M USD |
| Interest income | 156.53K USD | 298.12K USD | 428.39K USD | 10.97K USD | — |
| Interest expense | 14.37K USD | 10.11K USD | — | — | — |
| Depreciation and amortization | 323.65K USD | 339.56K USD | 359.06K USD | 240.89K USD | 123.69K USD |
| Operating income | −7.29M USD | −9.34M USD | −12.64M USD | −11.9M USD | −10.42M USD |
| Net income | −7.15M USD | −13.39M USD | −12.21M USD | −12.03M USD | −10.42M USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest fiscal-year EPS
- -10.61
- FY2026
- Latest fiscal-year revenue
- 0 USD
- FY2026
- Next fiscal-year EPS consensus
- -6.49
- FY2027 · 2 analysts
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Recent analyst actions
AEMD news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Aug 4, 2026 | 1:5 | — | — |
Stock split | Oct 20, 2025 | 1:10 | — | — |
Stock split | Jun 9, 2025 | 1:8 | — | — |
Stock split | Oct 5, 2023 | 1:10 | — | — |
Stock split | Oct 15, 2019 | 1:15 | — | — |
Stock split | Apr 14, 2015 | 1:50 | — | — |
Effective Aug 4, 2026
1:5
Effective Oct 20, 2025
1:10
Effective Jun 9, 2025
1:8
Effective Oct 5, 2023
1:10
Effective Oct 15, 2019
1:15
Effective Apr 14, 2015
1:50
AEMD peers
Continue in GoAI
Research AEMDresearch.disclaimer